Yu Zeng

机构：Tongji University, Shanghai Jiao Tong University, Liaoning Vocational College of Medical, Liaoning Provincial People's Hospital, Tongji Hospital, Southwest Minzu University, China Medical University · ORCID：0000-0001-8978-0338

发表论文 56 篇 · 总被引 837 次 · h-index 17

代表论文

• m6A-modified circFNDC3B inhibits colorectal cancer stemness and metastasis via RNF41-dependent ASB6 degradation (2022 · Cell Death and Disease · 被引 50)
• SEC61G assists EGFR -amplified glioblastoma to evade immune elimination (2023 · Proceedings of the National Academy of Sciences · 被引 32)
• Regular proton pump inhibitor use and incident dementia: population-based cohort study (2022 · BMC Medicine · 被引 28)
• FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2‐Mediated Alternative Splicing (2023 · Advanced Science · 被引 20)
• Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis (2022 · Cell Death Discovery · 被引 17)
• A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma (2022 · Frontiers in Cell and Developmental Biology · 被引 16)